Podcast: Meet our researchers
The COPCOV Trial’s position statement on “A living WHO guideline on drugs to prevent COVID-19.”
Following WHO recommendations against the use of hydroxychloroquine in the prevention of COVID-19, including its use in controlled trials, we are reviewing the guideline and available evidence. We are concerned that this judgement from the authors of the guideline is scientifically unsound.
What's new
Latest publications
-
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.
Journal article
Ogbe A. et al, (2021), Nature communications, 12
-
Improving Treatment and Outcomes for Melioidosis in Children, Northern Cambodia, 2009-2018.
Journal article
Chandna A. et al, (2021), Emerg Infect Dis, 27, 1169 - 1172
-
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
Journal article
Hall VJ. et al, (2021), The Lancet